Territoire riche d’une exceptionnelle biodiversité soumis à une intense activité humaine, la Méditerranée doit faire face à de nombreux enjeux au regard du changement climatique. Elle a toutefois beaucoup de possibilités pour relever ces défis en s’investissant dans la définition de solutions bâties sur un dialogue élargi à tous les acteurs de la région. C’est précisément le rôle de l’Union pour la Méditerranée de faire émerger des initiatives visant à renforcer la coopération dans ce domaine. Malgré le caractère très récent de son mandat politique sur les questions climatiques - qui date de mai 2014 -, l’Union pour la Méditerranée, à travers notamment son Groupe d’experts sur le changement climatique, a d’ores et déjà entrepris d’identifier des initiatives phares concrètes pour mieux répondre aux enjeux en question.
Background: Risk of acute organ failure (AOF) in cancer patients on systemic antineoplastic treatment is unknown. However, up to 5% of non-hematologic and 15% of hematologic cancer patients will need to be admitted to an intensive care unit (ICU). IPOPSCI-2017/01 is a prospective cohort study designed to ascertain the cumulative incidence of AOF and ICU admission in adult cancer patients. Methods: Single centre prospective cohort study with consecutive sampling of adult cancer patients admitted for unscheduled inpatient care while on, or up to 8 weeks after, systemic cancer treatment. Primary endpoints were cumulative risk of developing AOF and of ICU admission. Six months accrual expected an accrual of 400 patients to infer a population risk of ICU admission with a precision error of 2% and type 1 error of 5%. Results: Between August 2018 and February 2019, 10392 patients were on systemic anti-neoplastic treatment, 358 had unscheduled inpatient care and were eligible for inclusion and 285 were included. Mean age was 60.9 years-old, 50.9% were male, 52.3% had adjusted Charlson Comorbidity Index ≥3 and hematologic cancers accounted for 17.9% of patients. The cumulative risk of AOF on hospital admission was 29.5% (95%CI: 26-33) and during hospital stay was 39.6% (95%CI: 35-44). Cumulative risk of ICU admission of the patients with AOF was 15.0% (95%CI: 12-18) and if artificial life support criteria and AOF, cumulative risk of ICU admission was 31.5% (95%CI:CI: 23-40). On admission, 62.1% of patients were considered not eligible for artificial organ replacement therapy (no-AORT) and 34.3% of patients who developed AOF while in-hospital were judged no-AORT. Overall, 17 (15%) patients with AOF were admitted to ICU, 31.5% for AORT. Median follow up was 9.5 months. Inpatient mortality was 17.5%, with ICU mortality rate of 58.8%, with median cohort survival 134 days (95%CI: 106-162). On multivariate analysis, AOF was an independent poor prognostic factor (HR 1.6; 95%CI: 1.2-2.2). Conclusions: Risk of AOF in cancer patients admitted for unscheduled inpatient care while on systemic treatment is 39.6%, and risk of ICU admission is 15.0%. AOF in cancer patients was an independent poor prognostic factor for inpatient hospital stay and 6-months survival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.